Cargando…
LC-MS based sphingolipidomic study on A549 human lung adenocarcinoma cell line and its taxol-resistant strain
BACKGROUND: Resistance to chemotherapy drugs (e.g. taxol) has been a major obstacle in successful cancer treatment. In A549 human lung adenocarcinoma, acquired resistance to the first-line chemotherapy taxol has been a critical problem in clinics. Sphingolipid (SPL) controls various aspects of cell...
Autores principales: | Huang, Hao, Tong, Tian-Tian, Yau, Lee-Fong, Chen, Cheng-Yu, Mi, Jia-Ning, Wang, Jing-Rong, Jiang, Zhi-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083515/ https://www.ncbi.nlm.nih.gov/pubmed/30089463 http://dx.doi.org/10.1186/s12885-018-4714-x |
Ejemplares similares
-
LC-MS Based Sphingolipidomic Study on A2780 Human Ovarian Cancer Cell Line and its Taxol-resistant Strain
por: Huang, Hao, et al.
Publicado: (2016) -
Altered Mitochondrial Dynamics, Biogenesis, and Functions in the Paclitaxel-Resistant Lung Adenocarcinoma Cell Line A549/Taxol
por: Zhou, Xiang, et al.
Publicado: (2020) -
Sphingolipidomic Profiling of Rat Serum by UPLC-Q-TOF-MS: Application to Rheumatoid Arthritis Study
por: Qu, Fanghui, et al.
Publicado: (2018) -
Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics
por: Merrill, Alfred H.
Publicado: (2011) -
LC–MS Based Metabolomics Study of the Effects of EGCG on A549 Cells
por: Pan, Tingyu, et al.
Publicado: (2021)